{"podcast":{"title":"The Uromigos","slug":"the-uromigos-1214845","podcast_index_feed_id":1214845,"rss_url":"https://anchor.fm/s/13347ea8/podcast/rss","website_url":"https://www.uromigos.org","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/3122074/3122074-1626815623969-26c22e1d3574c.jpg","author":"The Uromigos","episode_count":479,"summary":"Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London","last_synced_at":"2026-07-13T22:19:20.611456+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845"},"episode":{"title":"Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer","slug":"episode-504-asco-2026-adc-drug-development-in-urothelial-cancer","published_at":"2026-05-29T22:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer","show_page_url":"https://stenobird.com/podcast/the-uromigos-1214845","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-504-ASCO-2026---ADC-Drug-Development-in-Urothelial-Cancer-e3jsa4o","audio_url":"https://anchor.fm/s/13347ea8/podcast/play/120514136/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-25%2F424851413-44100-2-cf14be68f94d8.m4a","summary":"This episode with Gopa Iyer from MSKCC explores the latest advances in antibody drug conjugates (ADCs) in urothelial cancer, including data from EV302, novel ADCs targeting Nectin-4, and sequencing strategies. Experts discuss efficacy, safety, biomarkers, and future directions in bladder cancer treatment.","meta_description":"This episode with Gopa Iyer from MSKCC explores the latest advances in antibody drug conjugates (ADCs) in urothelial cancer, including data from EV302, no…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2432,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-504-asco-2026-adc-drug-development-in-urothelial-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}